BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8630378)

  • 1. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
    Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
    Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
    Blair A; Hogge DE; Sutherland HJ
    Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture.
    Terpstra W; Ploemacher RE; Prins A; van Lom K; Pouwels K; Wognum AW; Wagemaker G; Löwenberg B; Wielenga JJ
    Blood; 1996 Sep; 88(6):1944-50. PubMed ID: 8822911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
    Blair A; Sutherland HJ
    Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
    Vercauteren S; Zapf R; Sutherland H
    Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
    Terpstra W; Rozemuller H; Breems DA; Rombouts EJ; Prins A; FitzGerald DJ; Kreitman RJ; Wielenga JJ; Ploemacher RE; Löwenberg B; Hagenbeek A; Martens AC
    Blood; 1997 Nov; 90(9):3735-42. PubMed ID: 9345060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
    Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
    Sutherland HJ; Blair A; Zapf RW
    Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
    Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
    Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
    Ailles LE; Gerhard B; Kawagoe H; Hogge DE
    Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
    Delwel R; van Gurp R; Bot F; Touw I; Löwenberg B
    Leukemia; 1988 Dec; 2(12):814-9. PubMed ID: 3199876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
    Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
    Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo assays to study self-renewal and long-term expansion of genetically modified primary human acute myeloid leukemia stem cells.
    Schuringa JJ; Schepers H
    Methods Mol Biol; 2009; 538():287-300. PubMed ID: 19277587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
    Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri MA; Dick JE
    Nature; 1994 Feb; 367(6464):645-8. PubMed ID: 7509044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.
    Blair A; Hogge DE; Ailles LE; Lansdorp PM; Sutherland HJ
    Blood; 1997 May; 89(9):3104-12. PubMed ID: 9129012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.
    Taussig DC; Vargaftig J; Miraki-Moud F; Griessinger E; Sharrock K; Luke T; Lillington D; Oakervee H; Cavenagh J; Agrawal SG; Lister TA; Gribben JG; Bonnet D
    Blood; 2010 Mar; 115(10):1976-84. PubMed ID: 20053758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.